200 related articles for article (PubMed ID: 36244636)
1. Further Studies on the Role of BTBD9 in the Cerebellum, Sleep-like Behaviors and the Restless Legs Syndrome.
Lyu S; Xing H; Liu Y; Girdhar P; Yokoi F; Li Y
Neuroscience; 2022 Nov; 505():78-90. PubMed ID: 36244636
[TBL] [Abstract][Full Text] [Related]
2. The Role of BTBD9 in the Cerebellum, Sleep-like Behaviors and the Restless Legs Syndrome.
Lyu S; Xing H; DeAndrade MP; Perez PD; Yokoi F; Febo M; Walters AS; Li Y
Neuroscience; 2020 Aug; 440():85-96. PubMed ID: 32446853
[TBL] [Abstract][Full Text] [Related]
3. The Role of BTBD9 in Striatum and Restless Legs Syndrome.
Lyu S; Xing H; DeAndrade MP; Liu Y; Perez PD; Yokoi F; Febo M; Walters AS; Li Y
eNeuro; 2019; 6(5):. PubMed ID: 31444227
[TBL] [Abstract][Full Text] [Related]
4. The role of BTBD9 in the cerebral cortex and the pathogenesis of restless legs syndrome.
Lyu S; Xing H; DeAndrade MP; Perez PD; Zhang K; Liu Y; Yokoi F; Febo M; Li Y
Exp Neurol; 2020 Jan; 323():113111. PubMed ID: 31715135
[TBL] [Abstract][Full Text] [Related]
5. Motor restlessness, sleep disturbances, thermal sensory alterations and elevated serum iron levels in Btbd9 mutant mice.
DeAndrade MP; Johnson RL; Unger EL; Zhang L; van Groen T; Gamble KL; Li Y
Hum Mol Genet; 2012 Sep; 21(18):3984-92. PubMed ID: 22678064
[TBL] [Abstract][Full Text] [Related]
6. BTBD9 and dopaminergic dysfunction in the pathogenesis of restless legs syndrome.
Lyu S; Doroodchi A; Xing H; Sheng Y; DeAndrade MP; Yang Y; Johnson TL; Clemens S; Yokoi F; Miller MA; Xiao R; Li Y
Brain Struct Funct; 2020 Jul; 225(6):1743-1760. PubMed ID: 32468214
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of Meis1, a transcriptional regulator, in mice and worms: Neurochemical and behavioral characterizations with implications in the restless legs syndrome.
Lyu S; Xing H; Liu Y; Girdhar P; Zhang K; Yokoi F; Xiao R; Li Y
J Neurochem; 2020 Dec; 155(5):522-537. PubMed ID: 32910473
[TBL] [Abstract][Full Text] [Related]
8. Enhanced hippocampal long-term potentiation and fear memory in Btbd9 mutant mice.
DeAndrade MP; Zhang L; Doroodchi A; Yokoi F; Cheetham CC; Chen HX; Roper SN; Sweatt JD; Li Y
PLoS One; 2012; 7(4):e35518. PubMed ID: 22536397
[TBL] [Abstract][Full Text] [Related]
9. Association of BTBD9 and MAP2K5/SKOR1 With Restless Legs Syndrome in Chinese Population.
Li G; Tang H; Wang C; Qi X; Chen J; Chen S; Ma J
Sleep; 2017 Apr; 40(4):. PubMed ID: 28329290
[TBL] [Abstract][Full Text] [Related]
10. Association of restless legs syndrome variants in Korean patients with restless legs syndrome.
Kim MK; Cho YW; Shin WC; Cho JW; Shon YM; Kim JH; Yang KI; Earley CJ; Allen RP
Sleep; 2013 Dec; 36(12):1787-91. PubMed ID: 24293752
[TBL] [Abstract][Full Text] [Related]
11. Rotigotine suppresses sleep-related muscle activity augmented by injection of dialysis patients' sera in a mouse model of restless legs syndrome.
Muramatsu K; Chikahisa S; Shimizu N; Séi H; Inoue Y
Sci Rep; 2019 Nov; 9(1):16344. PubMed ID: 31704978
[TBL] [Abstract][Full Text] [Related]
12. Analysis of functional GLO1 variants in the BTBD9 locus and restless legs syndrome.
Gan-Or Z; Zhou S; Ambalavanan A; Leblond CS; Xie P; Johnson A; Spiegelman D; Allen RP; Earley CJ; Desautels A; Montplaisir JY; Dion PA; Xiong L; Rouleau GA
Sleep Med; 2015 Sep; 16(9):1151-5. PubMed ID: 26298793
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase Cγ in cerebellar Purkinje cells regulates Ca
Watanave M; Takahashi N; Hosoi N; Konno A; Yamamoto H; Yasui H; Kawachi M; Horii T; Matsuzaki Y; Hatada I; Hirai H
Proc Natl Acad Sci U S A; 2022 Feb; 119(7):. PubMed ID: 35145028
[TBL] [Abstract][Full Text] [Related]
14. MEIS1 and BTBD9: genetic association with restless leg syndrome in end stage renal disease.
Schormair B; Plag J; Kaffe M; Gross N; Czamara D; Samtleben W; Lichtner P; Ströhle A; Stefanidis I; Vainas A; Dardiotis E; Sakkas GK; Gieger C; Müller-Myhsok B; Meitinger T; Heemann U; Hadjigeorgiou GM; Oexle K; Winkelmann J
J Med Genet; 2011 Jul; 48(7):462-6. PubMed ID: 21572129
[TBL] [Abstract][Full Text] [Related]
15. BTBD9 attenuates manganese-induced oxidative stress and neurotoxicity by regulating insulin growth factor signaling pathway.
Chen P; Cheng H; Zheng F; Li S; Bornhorst J; Yang B; Lee KH; Ke T; Li Y; Schwerdtle T; Yang X; Bowman AB; Aschner M
Hum Mol Genet; 2022 Jul; 31(13):2207-2222. PubMed ID: 35134179
[TBL] [Abstract][Full Text] [Related]
16. Sleep fragmentation and motor restlessness in a Drosophila model of Restless Legs Syndrome.
Freeman A; Pranski E; Miller RD; Radmard S; Bernhard D; Jinnah HA; Betarbet R; Rye DB; Sanyal S
Curr Biol; 2012 Jun; 22(12):1142-8. PubMed ID: 22658601
[TBL] [Abstract][Full Text] [Related]
17. Hyperactivity, dopaminergic abnormalities, iron deficiency and anemia in an in vivo opioid receptors knockout mouse: Implications for the restless legs syndrome.
Lyu S; DeAndrade MP; Mueller S; Oksche A; Walters AS; Li Y
Behav Brain Res; 2019 Nov; 374():112123. PubMed ID: 31376441
[TBL] [Abstract][Full Text] [Related]
18. The BTBD9 gene may be associated with antipsychotic-induced restless legs syndrome in schizophrenia.
Kang SG; Lee HJ; Park YM; Yang HJ; Song HM; Lee YJ; Cho SJ; Cho SN; Kim L
Hum Psychopharmacol; 2013 Mar; 28(2):117-23. PubMed ID: 23361623
[TBL] [Abstract][Full Text] [Related]
19. Probe the relationship between
Lyu S; Doroodchi A; Sheng Y; DeAndrade MP; Yang Y; Liu Y; Miller MA; Xiao R; Li Y
Exp Results; 2020; 1():. PubMed ID: 34268480
[TBL] [Abstract][Full Text] [Related]
20. Mu opioid receptor knockout mouse: Phenotypes with implications on restless legs syndrome.
Lyu S; DeAndrade MP; Unger EL; Mueller S; Oksche A; Walters AS; Li Y
J Neurosci Res; 2020 Aug; 98(8):1532-1548. PubMed ID: 32424971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
